Share of new medicines in R&D pipeline worldwide 2022, by therapy class
As of September 2022, 15 percent of new medicines in the R&D pipeline worldwide were medicines for infectious diseases, while immunology medicines accounted for four percent of new medicines in the R&D pipeline. This graph illustrates the distribution of new medicines in the R&D pipeline worldwide, by therapeutic class.